Non-Profit Focus AIM-HI Accelerator Fund operates as a non-profit organization dedicated to advancing innovative cancer treatments by supporting early-stage oncology startups, presenting opportunities to collaborate on philanthropic initiatives or sponsored research campaigns.

Funding and Grants With annual revenues between one and ten million dollars and recent investments in biotech startups like DotBio, there is potential to explore additional funding collaborations, grants, or partnership opportunities to further accelerate cancer research innovations.

Gender-Focused Programs The organization’s emphasis on empowering women entrepreneur-scientists through initiatives like the Women’s Venture Competition indicates open avenues for partnership in women-led biotech projects and equity-focused funding opportunities.

Awards and Recognition Recognition such as awards for leadership and nominations for industry accolades enhances credibility, making AIM-HI a valuable partner for co-hosting events, joint ventures, or sponsorships aimed at fostering innovative cancer solutions.

Recent Investment Activity The recent $5.6 million investment in DotBio highlights their active engagement in biotech funding, suggesting opportunities to provide specialized investment products, advisory services, or syndicate participation in upcoming oncology-focused funding rounds.